ECH1

Across TCGA pan-cancer cohorts, ECH1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ECH1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ECH1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ECH1 is over-expressed in tumor, although a few such as HNSC and CCRCC show the opposite, repressed pattern.

HNSC, CCRCC, and COAD are the cancer types where ECH1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ECH1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	−0.772	<.001	11	view →
CCRCC	Female	II,III,IV	−0.703	<.001	11	view →
COAD	Female	III,IV	−0.485	<.001	10	view →
PDAC	Male	All	+0.265	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

ECH1–HNSC

Open the HNSC breakdown →